RVL Pharmaceuticals PLC RVLP:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 06/24/22 EDT
1.19quote price arrow down-0.06 (-4.80%)
Volume
1,395
Close
1.25quote price arrow down-0.04 (-3.10%)
Volume
96,908
52 week range
0.98 - 4.38
Loading...
  • Open1.36
  • Day High1.36
  • Day Low1.25
  • Prev Close1.25
  • 52 Week High4.38
  • 52 Week High Date08/13/21
  • 52 Week Low0.98
  • 52 Week Low Date12/17/21

Key Stats

  • Market Cap104.44M
  • Shares Out83.55M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta1.50
  • YTD % Change15.74

KEY STATS

  • Open1.36
  • Day High1.36
  • Day Low1.25
  • Prev Close1.25
  • 52 Week High4.38
  • 52 Week High Date08/13/21
  • 52 Week Low0.98
  • 52 Week Low Date12/17/21
  • Market Cap104.44M
  • Shares Out83.55M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta1.50
  • YTD % Change15.74

RATIOS/PROFITABILITY

  • EPS (TTM)-1.09
  • P/E (TTM)-1.14
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-58.228M
  • ROE (TTM)-98.14%
  • Revenue (TTM)38.01M
  • Gross Margin (TTM)86.63%
  • Net Margin (TTM)-199.68%
  • Debt To Equity (MRQ)67.09%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On RVL Pharmaceuticals PLC

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
RVL Pharmaceuticals plc is a specialty pharmaceutical company. The Company is focused on the commercialization and development of products that target markets with underserved patient populations in the ocular medicine and medical aesthetics therapeutic areas. The Company delivers RVL-1201 (Upneeq), (oxymetazoline hydrochloride ophthalmic solution), 0.1%, for the treatment of acquired blepharoptosis, more commonly known as droopy or low-lying eyelids, in adults. Upneeq is the...
Brian Markison
Chairman of the Board, Chief Executive Officer, Chief Financial Officer
James Schaub
Chief Operating Officer, Executive Vice President
Tina deVries Ph.D.
Executive Vice President - Research and Development
Christopher Klein J.D.
General Counsel, Secretary
Address
400 Crossing Blvd
Bridgewater, NJ
08807-2863
United States

Top Peers

SYMBOLLASTCHG%CHG
AZYO
Aziyo Biologics Inc
7.23+0.52+7.75%
LJPC
La Jolla Pharmaceutical Co
3.46+0.08+2.37%
MEIP
MEI Pharma Inc
0.633+0.0205+3.35%
CASI
CASI Pharmaceuticals Inc
2.96-0.13-4.21%
CPIX
Cumberland Pharmaceuticals Inc
2.10+0.09+4.48%